Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

International Hypoglycaemia Study Group

doi:10.1007/s00125-016-4146-6

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

International Hypoglycaemia Study Group

Research output: Contribution to journal › Article › peer-review

88 Citations (Scopus)

249 Downloads (Pure)

Original language	English
Journal	Diabetologia
DOIs	https://doi.org/10.1007/s00125-016-4146-6
Publication status	Published - 21 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-016-4146-6Licence: CC BY

Final Published Version
Copyright The Author(s) 2016. This article is published with open access at Springerlink.com. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Final published version, 320 KBLicence: CC BY

Cite this

@article{c3bdfdde4663408f97a2a8ae320e5672,

title = "Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes",

author = "{International Hypoglycaemia Study Group} and Rory McCrimmon",

note = "The International Hypoglycaemia Study Group (IHSG) is supported through an unrestricted educational grant from Novo Nordisk awarded to Six Degrees Academy (SDA) of Toronto, ON, Canada.",

year = "2016",

month = nov,

day = "21",

doi = "10.1007/s00125-016-4146-6",

language = "English",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials

T2 - a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

AU - International Hypoglycaemia Study Group

AU - McCrimmon, Rory

N1 - The International Hypoglycaemia Study Group (IHSG) is supported through an unrestricted educational grant from Novo Nordisk awarded to Six Degrees Academy (SDA) of Toronto, ON, Canada.

PY - 2016/11/21

Y1 - 2016/11/21

U2 - 10.1007/s00125-016-4146-6

DO - 10.1007/s00125-016-4146-6

M3 - Article

C2 - 27872948

SN - 0012-186X

JO - Diabetologia

JF - Diabetologia

ER -